Kewaunee Scientific (KEQU) Receivables (2011 - 2026)

Kewaunee Scientific's Receivables history runs 16 years deep, the most recent figure standing at $14.2 million for Q2 2026.

• On a quarterly basis, Receivables fell 77.3% year-over-year to $14.2 million in Q2 2026; TTM through Apr 2026 was $14.2 million, a 77.3% decrease from a year earlier, with the FY2026 full-year figure at $58.7 million, down 5.84% from the prior year.
• Receivables declined to $14.2 million in Q2 2026 per KEQU's latest filing, from $54.1 million in the prior quarter.
• Across five years, Receivables topped out at $62.4 million in Q2 2025 and bottomed at $9.3 million in Q2 2022.
• The 5-year median for Receivables is $42.2 million (2023), against an average of $39.5 million.
• Across the five-year window, Receivables jumped 426.89% in 2025 and plunged 77.3% in 2026, its largest moves.
• Year by year, Receivables stood at $41.5 million in 2022, then climbed by 2.72% to $42.6 million in 2023, then decreased by 1.68% to $41.9 million in 2024, then soared by 40.9% to $59.0 million in 2025, then sank by 76.0% to $14.2 million in 2026.
• Per Business Quant, the three latest KEQU Receivables figures stand at $14.2 million (Q2 2026), $54.1 million (Q1 2026), and $59.0 million (Q4 2025).